AUCH Medical Directors Peer Group

Update on 340B contract pharmacy issue 

10-12-2021 11:39

This article (see link) was published in the National Law Review on September 24, 2021 and summarizes the status of HRSA’s actions against the six drug manufacturers that stopped shipping 340B priced drugs to contract pharmacies. The progress against the manufacturers is very slow, but this referral to OIG is a positive development: HRSA Refers Six Drug Manufacturers to OIG for Possible 340B-Related Civil Penalties

Statistics
0 Favorited
2 Views
0 Files
0 Shares
0 Downloads

Tags and Keywords

Related Entries and Links

No Related Resource entered.